Replacement therapy in myeloma or chronic lymphocytic leukaemia (CLL) with severe secondary hypogammaglobulinemia and recurrent infections; replacement therapy in children with congenital AIDS and recurrent infections The recommended dose is 0.2-0.4 g/ kg BW every three to four weeks.